Celgene was among the investors helping the cancer cell-therapy developer increase its total funding to approximately $110m.

The Telstra and NTT Docomo-backed identity verification platform developer took its total funding past the $110m mark with a Sapphire Ventures-led round.

Celsius Therapeutics, which has launched with series A capital, has become the latest Third Rock-launched company to be backed by GV.

Hearst Financial Venture Fund helped TruValue Labs, the developer of an AI-equipped data platform for investors, close the round at $13.6m.

Bitmain led the cryptofinance technology producer's latest round at a reported valuation of almost $3bn, six times that of its series D.

Daily fantasy sports platform FanDuel is in talks to be acquired by Paddy Power Betfair, allowing Comcast, Time Warner and Alphabet to exit.

University of Birmingham has spun out Viatem to develop a treatment for rheumatoid arthritis.

The Cambridge spinout has raised $15m in series A funding from investors including Cambridge Enterprise and Parkwalk Advisors.